Teva Pharmaceutical Industries (TEVA) Shares Issued (2009 - 2018)

Teva Pharmaceutical Industries (TEVA) has reported Shares Issued for 9 consecutive years, with $48.4 million the latest figure, recorded in Q4 2018.

• Quarterly Shares Issued changed N/A year-over-year to $48.4 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $48.4 million (changed N/A YoY) and the FY2018 annual result came in at $48.4 million, changed N/A from the prior year.
• Shares Issued advanced to $48.4 million in Q4 2018 per TEVA's latest filing, from $32.8 million in the prior quarter.
• Over the last five years, Shares Issued for TEVA reached as high as $48.4 million in Q4 2018 and fell as low as $25.2 million in Q4 2015.
• A 4-year average of $33.3 million and a median of $29.8 million in 2014 frame the typical range for Shares Issued.
• Annual changes were most pronounced in 2014 — Shares Issued retreated 17.7% — and 2016, when it increased 29.94%.
• Year by year, Shares Issued stood at $26.7 million in 2014, then dropped by 5.61% to $25.2 million in 2015, then climbed by 29.94% to $32.8 million in 2016, then surged by 47.59% to $48.4 million in 2018.
• According to Business Quant data, Shares Issued over the past three periods registered $48.4 million, $32.8 million, and $25.2 million for Q4 2018, Q4 2016, and Q4 2015 respectively.